Skip to content

Traditional Septoplasty Vs Endoscopic Septoplasty for Treating Deviated Nasal Septum

Traditional Septoplasty Vs Endoscopic Septoplasty for Treating Deviated Nasal Septum: A Prospective, Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02653950
Enrollment
60
Registered
2016-01-13
Start date
2016-02-29
Completion date
Unknown
Last updated
2016-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intranasal Surgery

Brief summary

In this study the investigators aim to assess whether endoscopic septoplasty is effective at improving patients QOL and reducing postoperative signs and complications. Primary outcome: To assess the differences in overall QOL between endoscopic and traditional septoplasty after adjusting for pertinent confounding variables. Secondary outcomes: 1. To evaluate the post-operative complication rate in patients undergoing endoscopic septoplasty compared to traditional. 2. To evaluate the differences in the operation time between the two different approaches.

Detailed description

Nasal obstruction is one of the most common complaints that the otorhinolaryngologist faces in the daily practice. Deviated nasal septum (DNS) is a very frequently encountered and common cause. It not only causes breathing difficulties but also results in improper aeration of paranasal sinuses predisiposing to sinusitis and also results in drying of mucosa leading to crusting and epistaxis 1,2. DNS can also be accompanied with hypertrophic nasal turbinates causing sleep disturbances and snoring3. Septoplasty is an accepted and common surgical intervention to improve the nasal airway4 and sleep disturbances3. Traditional septoplasty procedure involves sum mucosal resection of the anterior septum. The results for long-term symptom relief after traditional septoplasty are contradictory in reviewed publications 5. In the last two decades the endoscopic Sino nasal surgery has been widely used including endoscopic approach for septoplasty. Endoscopic septoplasty as a minimally invasive technique where the dissection of the nasal septal flap can be limited minimizing trauma. The excellent visualization is presumed to decrease morbidity and post-operative swelling in isolated septal deviation by limiting the excision to the area of deviation 2. Furthermore, diagnosing and treating abnormalities of the lateral wall of the nose at the same sitting is only feasible in the endoscopic approach. At the time of this study, there are no studies comparing the changes of quality of life in patients undergoing traditional septoplasty Vs endoscopic septoplasty. The investigators aimed to assess whether endoscopic septoplasty is effective at improving patients QOL and reducing postoperative signs and complications. Aims Primary: 1\) To assess the differences in overall QOL between endoscopic and traditional septoplasty after adjusting for pertinent confounding variables. Secondary: 1. To evaluate the post-operative complication rate in patients undergoing endoscopic septoplasty compared to traditional. 2. To evaluate the differences in the operation time between the two different approaches.

Interventions

Endoscopic surgery; septoplasty with or without middle turbenectomy

PROCEDURETraditional septoplasty

septoplasty under direct vision

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of nasal obstruction and deviated nasal septum with or without hypertrophy of nasal turbinates. 2. Patient undergoing surgery for repairing the deviated nasal septum.

Exclusion criteria

1. Diagnosis of bilateral acute or chronic rhinosinusitis or nasal polyposis 2. Patients undergoing endoscopic sinonasal surgery. 3. Diagnosed with inflammatory (e.g. Wegener's granulomatosis, sarcoidosis) or neoplastic nasal pathology 4. Diagnosed with systemic conditions affecting the nose e.g. Cystic fibrosis, Kartagener's syndrome 5. Patients listed for revision surgery 6. Neoplasms - untreated or under active or recent treatment with chemotherapy or radiotherapy 7. Unable to give informed consent due to mental impairment 8. Unable to adhere follow up or treatment.

Design outcomes

Primary

MeasureTime frameDescription
Change in Quality of lifeBaseline (maximum 3 months before surgery), at 2-3 weeks, and 3-4 months after the surgery.quality of life will assessed using Sino-Nasal Outcome Test-22 (SNOT-22) scores.

Contacts

Primary ContactShorook Na'ara, MD
shorook.n@gmail.com00972507977510

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026